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Skeletal Cell Fate Decisions Within Periosteum and Bone Marrow
During Bone Regeneration
Ce ´line Colnot
ABSTRACT: Bone repair requires the mobilization of adult skeletal stem cells/progenitors to allow depo-
sition of cartilage and bone at the injury site. These stem cells/progenitors are believed to come from multiple
sources including the bone marrow and the periosteum. The goal of this study was to establish the cellular
contributions of bone marrow and periosteum to bone healing in vivo and to assess the effect of the tissue
environment on cell differentiation within bone marrow and periosteum. Results show that periosteal injuries
heal by endochondral ossiﬁcation, whereas bone marrow injuries heal by intramembranous ossiﬁcation,
indicating that distinct cellular responses occur within these tissues during repair. Next, lineage analyses were
used to track the fate of cells derived from periosteum, bone marrow, and endosteum, a subcompartment of
the bone marrow. Skeletal progenitor cells were found to be recruited locally and concurrently from peri-
osteum and/or bone marrow/endosteum during bone repair. Periosteum and bone marrow/endosteum both
gave rise to osteoblasts, whereas the periosteum was the major source of chondrocytes. Finally, results show
that intrinsic and environmental signals modulate cell fate decisions within these tissues. In conclusion, this
study sheds light into the origins of skeletal stem cells/progenitors during bone regeneration and indicates
that periosteum, endosteum, and bone marrow contain pools of stem cells/progenitors with distinct osteo-
genic and chondrogenic potentials that vary with the tissue environment.
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INTRODUCTION
B
ONE REGENERATION IS largely dependent on a success-
ful inﬂammatory response, revascularization of the
injury site, secretion of osteogenic and chondrogenic fac-
tors, and remodeling of the extracellular matrix within the
damaged and new bone tissues.
(1–6) Less is known about
the origins of cells that produce bone and cartilage at the
injury site. Several potential sources of skeletal stem cells/
progenitors have been identiﬁed that may participate in
bone repair. Cells may be delivered through the vascula-
ture
(7–9) and may be recruited from bone itself
(10–14) or
tissues immediately adjacent to bone, such as fat, tendon,
and muscle.
(15–17) Several lines of evidence suggest that the
periosteum and the bone marrow are the main local sour-
ces of skeletal stem cells/progenitors for bone repair. Me-
chanical disruption of the periosteum or bone marrow
delays healing,
(18,19) presumably by removing the local
source of cells. Although cells isolated from the periosteum
or bone marrow can differentiate into chondrocytes and/or
osteoblasts in vitro,
(10,11,13,14) in vivo studies on the chon-
drogenic and osteogenic potentials of periosteum and bone
marrow are limited.
(20–22) Therefore, we still lack direct
evidence showing the cellular contribution of periosteum
and bone marrow to bone healing.
The difﬁculty in separating the role of various sources of
cells during skeletal regeneration arises in part from the
intricate structure of bone and the multiple tissues in-
volved. In the majority of bone injuries, cortical bone is
broken, thereby permitting communication between the
periosteum, the bone marrow, and surrounding soft tissues.
Moreover, when the physical barrier between bone com-
partments is disrupted, the healing response in one tissue
may impinge on the response in the adjacent tissue through
the diffusion of cells and growth factors. The goal of this
study was to assess the extent to which periosteum and bone
marrow contribute to osteogenic and chondrogenic line-
ages during bone repair and the extent to which the en-
vironment inﬂuences cell fate decisions in these tissues.
In vivo cell lineage analyses were developed to track
cells derived from periosteum, bone marrow, and endos-
teum, a speciﬁc compartment of the bone marrow lining
the inner surface of bone. Bone grafts were collected from
genetically labeled mice (Rosa26) and transplanted into
wildtype hosts. Because the integrity of the periosteum,
endosteum, and/or bone marrow was preserved during
transplantation, labeled cells were recruited from their
original niche and the fate of these cells was followed
during bone healing. Results show that cells derived from
the three tissues contribute differently to healing by
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274intramembranous and endochondral ossiﬁcation. This
study also demonstrates that both intrinsic and environ-
mental signals modulate cell fate decisions within perios-
teum, bone marrow, and endosteum during bone repair.
MATERIALS AND METHODS
Periosteal and endosteal/bone marrow injuries
All procedures followed protocols approved by the UCSF
Animal Care and Use Committee. Adult C57B6 wildtype
mice (males, 3–4 mo old) were anesthetized with an intra-
peritoneal injection of ketamine-metedomidin. To create
periosteal injuries, an incision was made over the anterior-
proximal tibia. The anterior-proximal tibial surface was ex-
posed,andtheperiosteum was partiallystrippedusingarazor
blade. Tears covered an area of 3–4 mm in length. Wounds
were closed with size 6-0 nylon sutures. After surgery, mice
received subcutaneous injections of buprenorphine for anal-
gesia and were allowed to ambulate freely. Mice were killed
by cervical dislocation after anesthesia at days 3 (n=3 ) ,5( n=
3), 7 (n =6 ) ,1 0( n =6 ) ,a n d1 4( n = 4) after surgery.
To create endosteal/bone marrow injuries, an incision was
made at the knee joint. An insect pin (Fine Science Tools)
was inserted from the joint into the intramedullary cavity,
andtheendosteum/bonemarrowwasreamed.Woundswere
closedafterremovingtheinsectpin.Micewerekilledatdays
5( n =2 ) ,7( n = 6), 10 (n =4 ) ,a n d1 4( n =3 ) .
Preparation of bone grafts
Bone grafts were isolated from Rosa26 donors (males, 10
wk old) that express the LacZ reporter gene ubiquitously
in the C57B6 background. Mice were killed after anesthesia.
The tibias were collected free of skin and surrounding
muscles. A fragment of cortical bone was cut (;2m mi n
length and 1mm in width) in the anterior-proximal area of
each tibia using scissors. To follow cells derived from the
periosteum,the endosteum andbonemarrowwereremoved
from the graft using a razor blade. The opposite was done to
follow cells derived from endosteum and bone marrow. To
follow cells derived from the endosteum, periosteum and
bone marrow were removed but the endosteal surface was
left intact. Negative controls were obtained by removing
both the periosteum and bone marrow/endosteum from the
graft, and positive controls by keeping intact both the peri-
osteum and bone marrow/endosteum.
Transplantation of bone grafts
Host C57B6 mice (males, 10 wk old) were prepared by
creating a cortical defect on the anterior-proximal surface of
the tibia. Under anesthesia, the tibial surface was exposed
and a unicortical defect of ;2m mi nl e n g t ha n d1m mi n
width was created with a slow-speed dental engine using a
0.8-mm drill bit. To create nonstabilized fractures, three
holes (0.4 mm in diameter) were drilled on the opposite side
of the tibial cortex adjacent to the graft, and the bone was
tapped until a fracturewas created.Holes werenotdrilledin
the opposite cortex of mice given grafts but no fracture.
The graft was placed in the cortical defect of host mice
with or without fracture. The graft was oriented with the
endosteum facing the marrow cavity of the host tibia or
switched with the endosteum facing the soft tissue sur-
rounding the external surface of the host bone. If needed,
the size of the graft was adjusted to ﬁt perfectly in the
defect to prevent movement of the graft and to allow rapid
integration within the cortex of the host tibia. The muscle
was sutured over the defect to hold the graft in place,
and wounds were closed. Mice were killed at days 5, 7, 10,
and 14 (day 5, n = 2; day 7, n = 1 or 2 per group with normal
orientation; days 10 and 14, n = 3–10 per group; Table 1).
Tissue processing and cell lineage analyses
Tibias were harvested and ﬁxed for 24 h at 48Ci na
solution containing 0.2% glutaraldehyde, 2 mM MgCl2,
and 5 mM EDTA in PBS and washed three times for 1 h
in a solution containing 2 mM MgCl2,0 . 0 1 %s o d i u m -
deoxycholate, and 0.02% NP40 in PBS. Samples were
TABLE 1. PROPORTIONS OF SAMPLES WITH CONTRIBUTION OF DONOR PO, EO, AND EO/BM TO BONE AND CARTILAGE DURING
BONE GRAFT HEALING AND NONSTABILIZED FRACTURE HEALING
Bone graft healing Nonstabilized fracture healing
Contribution to bone Contribution to bone Contribution to cartilage
PO EO EO/BM PO EO EO/BM PO EO EO/BM
Normal graft orientation
PO intact 5/5 0/5 0/5 9/10 0/10 0/10 5/5 0/5 0/5
EO intact 0/7 7/7 — 0/6 6/6 — 0/6 0/6 —
EO/BM intact 0/5 — 5/5 0/5 — 5/5 0/5 — 2/5*
EO/PO intact 8/8 8/8 — 6/6 6/6 — 4/6 0/6 —
EO/PO removed 0/3 0/3 — 0/4 1/4 — 1/4 0/4 —
Graft orientation switched
PO intact 4/4 0/4 0/4 6/6 0/6 0/6 4/6 0/6 0/6
EO intact 0/5 5/5 — 0/5 5/5 — 0/4 2/4* —
EO/BM intact 0/5 — 5/5 0/5 — 5/5 0/5 — 5/5*
EO/PO intact 4/4 4/4 — 5/5 5/5 — 5/5 2/5* —
EO/PO removed 0/4 0/4 — 0/3 0/3 — 0/3 0/3 —
*Samples with minimal cellular contribution to cartilage.
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(23)
Longitudinal 8-mm-thick sections through the bone graft
and the fracture callus were collected and stained with X-
gal as previously described.
(23) To identify which cell type
the periosteum, bone marrow, and endosteum give rise to,
Safranin-O/Fast Green and trichrome staining were per-
formed to visualize cartilage and bone, respectively.
RESULTS
Comparing the mechanisms of healing in the
periosteum and endosteum/bone marrow
To determine the intrinsic healing programs within
periosteum and bone marrow/endosteum, injuries were
created in one tissue without damaging the other. After
periosteal injury, a thickening of the periosteum was ob-
served at day 5 after surgery (data not shown). By day 7,
cartilage and bone were detected along the periosteal
surface (Fig. 1A). Cartilage was subsequently degraded
and replaced by bone. By day 14, the periosteal surface was
covered with woven bone that was being actively re-
modeled by osteoclasts (Fig. 1B and data not shown).
These results indicate that injury to the periosteum induces
repair through endochondral ossiﬁcation. Conversely,
reaming of the bone marrow/endosteal surface did not
stimulate chondrogenesis. By day 7 after injury, the mar-
row cavity and endosteal surfaces were ﬁlled with new
woven bone (Fig. 1C), which was largely resorbed by day
14 (Fig. 1D). Cartilage was not detected at any stages ob-
served, showing that bone marrow/endosteal injuries
healed by intramembranous ossiﬁcation.
Lineage analysis approach to follow periosteum- and
bone marrow–derived cells during bone healing
To distinguish the role of the periosteum and bone marrow/
endosteum in more complex healing environments, lineage
analyses were performed using a combination of bone graft-
ing and genetic labeling (Fig. 2). Bone grafts were harvested
just before their transplantation, which allowed a high sur-
vival rate and successful integration of the grafts into the host
bone. Graft survival was assessed based on the presence of
X-gal–positive osteocytes throughout the cortex of the
graft and X-gal–positive cells throughout the periosteum
or bone marrow/endosteum at the surface of the graft.
In the vast majority of samples (67 of 74 grafts total evaluated
at days 10 and 14), osteocytes remained viable within the
cortical bone grafts as shown by the maintained expression of
b-gal throughout the course of healing. The graft did not
survive in only seven samples, which were discarded from the
study. In correlation with graft viability, the graft contributed
to bone repair because X-gal–positive osteoblasts and
osteocytes were present in the new bone being deposited.
Tracking periosteum- and bone marrow–derived cells
during bone graft healing
During healing of stabilized bone grafts, new bone formed
at the periosteal and endosteal surfaces and within the mar-
row cavity (Fig. 2). Woven bone accumulating at the bone graft
ends allowed bridging with the injured cortex. Cartilage was
not detected at any stages including days 5, 7, and 10, indicating
that bone grafts healed by intramembranous ossiﬁcation. To
assess the contribution of periosteum, endosteum, and bone
marrow to bone graft healing, the distribution of graft-derived
cells within the new bone was analyzed by X-gal staining on
tissue sections. Grafts with periosteum intact gave rise to os-
teoblasts and osteocytes at the graft periosteal surface (Figs.
2A–2C; Table 1), whereas grafts with endosteum intact gave
rise to osteoblasts and osteocytes at the endosteal surface(Figs.
2D–2F; Table 1). When the bone marrow was left attached to
the endosteum, graft-derived osteoblasts and osteocytes were
found in new bone both at the endosteal surface and within the
marrow cavity (Figs. 2G–2I; Table 1). In positive controls, la-
beled cells were detected both at the periosteal and endosteal
surfaces (Figs. 2J–2M; Table 1). In all these groups, graft-
derived cells were also found at the junction of the graft
and the old cortex, where a mixture of donor- and host-
derived osteoblasts/osteocytes formed the new bone con-
necting the graft and the host cortex. In negative controls,
no graft-derived osteoblasts and osteocytes were detected,
showing that cells within the cortex of the graft did not
participate in healing (Figs. 2N–2Q; Table 1). New
bone was deposited by cells derived from the host and al-
lowed bridging of the bone graft end; however, new bone
did not span the entire periosteal surface as seen in samples
with periosteum intact. X-gal–positive osteoclasts were
present at the surface of new (Figs. 2P and 2Q, arrowheads)
and old bone. Osteoclasts may have been derived both
from the donor and/or the host, because these cells express
b-galactosidase constitutively.
(23–25)
Tracking periosteum- and bone marrow–derived cells
during nonstabilized fracture healing
To compare the contribution of periosteum, endosteum,
and bone marrow to healing by endochondral ossiﬁcation, a
FIG. 1. Periosteal injuries heal by endochondral ossiﬁcation, whereas
endosteal/bone marrow injuries heal by intramembranous ossiﬁ-
cation. Longitudinal sections through the mouse tibia stained with
(A) Safranin-O/Fast Green (SO) and (B–D) trichrome (TC) at (A
and C) 7 and(B and D) 14 days after (A and B) periosteal (PO) or (C
and D) endosteal/bone marrow (EO/BM) injury. Scale bar = 200 mm.
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Fig. 1 is 4/Cnonstable fracture was created adjacent to the graft at the
time of bone grafting. Although fractures were not stabilized,
bone healing was not delayed compared with stabilized
fractures.
(3,26) In this model, endochondral ossiﬁcation is ini-
tiated at day 7.
(26) The optimal time points to assess cartilage
formation within the callus are days 10 and 14 postfracture,
with a peak observed at day 10 and the beginning of cartilage
replacement by bone at day 14.
(3,26) Bone formation was also
evaluated at these two time points.
As shown by histological analyses, the graft was inte-
grated into the fracture callus (Figs. 3 and 4). In samples
with periosteum intact, large cartilage islands that formed
adjacent to the periosteal surface of the graft were always
donor derived and therefore derived from the periosteum
(Figs. 3A and 3B; Table 1). Cartilage that formed at a
distance from the graft was host derived (data not shown).
Endosteum-derived chondrocytes were not detected within
the callus (Figs. 3C and 3D; Table 1). Endosteum/bone
marrow–derived chondrocyteswere detectedin onlytwo of
ﬁve cases and constituted only a small proportion of the
cartilage formed adjacent to the graft and close to the en-
dosteal surface (Figs. 3E and 3F; Table 1). In positive
controls, donor-derived chondrocytes were observed only
at the periosteal surface of the graft (Figs. 3G–3I; Table 1).
In negative controls, the graft did not give rise to cartilage
excluding the possibility that chondrocytes may be derived
from the cortex of the graft itself (Figs. 3J–3L; Table 1).
One sample exhibited a small amount of cartilage at the
periosteal surface, suggesting that the periosteum may not
have been completely removed in this case (Table 1). As
for all samples with periosteum removed, cartilage for-
mation was reduced or inhibited at the proximity of the
graft (Figs. 3C, 3E, and 3J, asterisks).
In parallel, we tracked graft-derived osteoblasts and os-
teocytes. Periosteum supplied osteoblasts and osteocytes at
the periosteal surface (Figs. 4A, 4B, 4G, and 4H; Table 1).
Endosteum and bone marrow provided osteoblasts and
osteocytes at the endosteal surface and within the bone
marrow (Figs. 4C–4G and 4I; Table 1). In negative controls,
osteoblasts and osteocytes were host derived except in one
case where endosteum was not completely removed (Figs.
4J–4L;Table1).Intheabsenceofperiosteum,bonebridging
was reduced at the periosteal surface (Figs. 4C, 4E, and 4J,
asterisks). Removal of endosteum and bone marrow did not
affect bone formation within the marrow cavity, indicating
that the host endosteum/bone marrow may compensate for
the absence of osteoblasts precursors attached to the graft.
FIG. 2. Periosteum and bone marrow/
endosteum give rise to osteoblasts/osteocytes
during bone graft healing. (Left) Schematic
representations of Rosa 26 (blue) or wild-
type bone grafts transplanted in the cortex of
wildtype host tibias. Longitudinal sections
through the mouse tibia stained with TC (mid-
dle) and adjacent sections stained with X-gal
(right) at 14 days after bone grafting. X-gal–
positive osteoblasts and osteocytes (arrow)
are found at the intact periosteal surface
(A–C), at the intact endosteal surface (D–F),
within the marrow cavity (G–I), and at both
periosteal and endosteal surfaces in positive
controls (J–M), but not in negative controls
(N–U). X-gal–positive osteoclasts express
b-galactosidase ubiquitously (K, L, T, and U,
arrowheads). Dotted orange lines delimit the
bone graft. High magniﬁcations correspond
to boxed areas. Scale bars: B, E, H, K, O, and
S = 1 mm; C, F, I, L, M, P, Q, and T = 100 mm;
U=2 0mm.
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Fig. 2 is 4/CEffects of the tissue environment on cell
differentiation within periosteum, bone marrow,
and endosteum
The differences among periosteum, endosteum, and
bone marrow in their cellular contribution to bone repair
may be caused by intrinsic differences within these tis-
sues or extrinsic differences in their environment. To dis-
tinguish between intrinsic versus extrinsic effects, the fate
of donor-derived cells was assessed when the orientation of
the grafts were switched to place the periosteum in the
environment of the endosteum/bone marrow and vice
versa. The effects of the tissue environment on cell dif-
ferentiation in the periosteum were assessed ﬁrst (Fig. 5A).
During healing of stabilized bone grafts, periosteum-
derived cells differentiated into osteoblasts and osteocytes
at the periosteal surface of the graft and within the marrow
cavity of the host bone (Figs. 5B and 5C; Table 1). During
healing of nonstabilized fractures, the periosteum gave rise
to osteoblast/osteocytes (Figs. 5D and 5E; Table 1) and
chondrocytes (Figs. 5F and 5G; Table 1) localized near
the grafted periosteum and within the host bone marrow
cavity. In all groups, no graft-derived cells were found at
the periosteal surface of the host bone (data not shown).
Next, the effects of the periosteal environment on cell
differentiation in the endosteum and bone marrow were
tested (Fig. 5H). Both endosteum and bone marrow gave
rise to osteoblast/osteocytes at the endosteal surface of the
graft during bone graft (Figs. 5I and 5J; Table 1) and
nonstable fracture healing (Figs. 5K and 5L; Table 1). Cells
derived from the donor endosteum or bone marrow were
not detected within the marrow cavity of the host bone
(data not shown). Within the fracture callus, donor en-
dosteum and bone marrow generated few X-gal–positive
chondrocytes in cartilage islands that were primarily host
derived (Figs 5M and 5N; Table 1). The proportion of
samples with endosteum- or endosteum/bone marrow–de-
rived chondrocytes was increased compared with experi-
ments with normal graft orientation (Table 1). Positive and
negative controls were obtained as in previous experiments
to conﬁrm and validate the results (Table 1). Therefore,
there were no changes in the osteogenic potentials of
periosteum, endosteum, and bone marrow when the ori-
entation of the grafts was reversed within the host bone.
Likewise, placing the periosteum in the environment of the
endosteum/bone marrow did not decrease its chondrogenic
potential. In contrast, placing the endosteum and bone
marrow in the environment of the periosteum increased
their chondrogenic potential. Even in this ectopic envi-
ronment, however, the endosteum/bone marrow was not as
potent as the periosteum to support cartilage formation
during fracture healing.
DISCUSSION
Cells are mostly recruited locally during bone repair
Whether bone healing is supported by multiple inter-
changeable sources of cells is still unclear. Lineage analyses
show that the origin of osteoblasts and chondrocytes de-
termines their location within the bone regenerate. Cells
derived from the periosteum are always found at the per-
iosteal surface, whereas cells derived from the endosteum
and the bone marrow are always found at the endosteal
surface or within the marrow cavity, respectively. Even
when the tissues are transplanted ectopically, cells do not
migrate from distant periosteal or bone marrow/endosteal
FIG. 3. Chondrocytes are primarily derived from the periosteum
during healing of nonstabilized fractures. Longitudinal sections
through the fracture callus stained with SO (left) and adjacent
sections stained with X-gal (right) 10 days after bone grafting and
nonstable fracture. (A and B) Cartilage (c) forming at the intact
periosteal surface stains positive with X-gal (arrow). Cartilage ad-
jacent to the intact endosteal surface is (C and D) X-gal negative or
(E and F) contains few X-gal–positive chondrocytes (arrow) when
bonemarrow isleftintact. (G–I) Inpositive controls, X-gal–positive
cartilage (arrow) is found at the periosteal surface and X-gal neg-
ativecartilageattheendostealsurfaceofthegraft.(J–L)Innegative
controls, no X-gal–positive chondrocytes are detected. Endogenous
b-galactosidase activity is detected in osteoclasts (arrowheads).
Asterisk indicates absence of cartilage in the anterior part of the
callus when the periosteum is removed. Dotted orange lines delimit
the bone graft and black dotted lines delimit the junction between
cartilage and bone within the callus. b, bone. Scale bars: A, C, E, G,
a n dJ=1m m ;B ,D ,F ,H ,I ,K ,a n dL=1 0 0mm.
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Fig. 3 is 4/Csources within the callus because they are never detected at
a distance from their original niche. Thus, bone itself seems
to be the main local source of cells for bone repair.
Data provided here and previous studies further support
this conclusion, because periosteum damage or removal af-
fects osteogenesis and chondrogenesis and delays heal-
ing.
(18,19) This delay most likely results from the removal of
the local source of cells. Cells recruited from other sources
mightcompensatefor the lackofperiosteum but take longer
to arrive at the site of injury.
(7,8,15–17,27) Severe trauma and
soft tissue damage have also been shown to impair bone
healing,
(28–30) which may be caused by the disruption of
direct contacts between the periosteum and the bone
matrix. These contacts may be important to preserve the
stem cell niche and promote osteogenesis and chondro-
genesis in vivo. Likewise, excessive mechanical disruption
of the bone marrow delays fracture healing probably by
deleting the mesenchymal stem cells (MSCs) and by dis-
turbing the inﬂammatory response.
(31,32)
Distinct cellular contributions of periosteum, bone
marrow, and endosteum to bone healing
Lineage analyses show that osteoblasts and osteocytes
originate from periosteum, bone marrow, and endosteum,
indicating that these three tissues contribute simulta-
neously to new bone forming by intramembranous and
endochondral ossiﬁcation. Chondrocytes within the frac-
ture callus, however, are primarily derived from the peri-
osteum. These results are consistent with the program of
bone healing observed after periosteal or bone marrow/
endosteal injuries, which heal by endochondral and intra-
membranous ossiﬁcation, respectively. These data thus
show that the periosteum supports both chondrogenesis
and osteogenesis, whereas bone marrow/endosteum sup-
ports osteogenesis during bone repair.
Intrinsic differences between periosteum and bone marrow/
endosteum inﬂuence cell fate decisions within these tissues.
Whether periosteum is placed in its original environment
or in the environment of the bone marrow, cells derived
from the periosteum can give rise to osteoblasts/osteocytes
or chondrocytes. Consequently, the lack of chondrocytes
recruited from endosteum during nonstabilized fracture
healing is not caused by the presence of inhibitors of chon-
drogenesis in the bone marrow but rather to distinct stem
cell populations/progenitors. Hence, the osteogenic and
chondrogenic potentials of the periosteum and bone mar-
row/endosteum may be deﬁned by distinct stem cell pop-
ulations/progenitors within these tissues. Intrinsic differ-
ences may also exist between endosteum and bone marrow
because the capacity to undergo chondrogenesis was im-
proved in samples with endosteum and bone marrow intact
compared with endosteum alone. MSCs have been reported
to reside in the stromal compartment of the bone mar-
row,
(12,33,34) and results presented here now suggest that the
endosteum may contain a distinct stem cell population
within the bone marrow cavity. Stem cell populations/pro-
genitors within periosteum and bone marrow/endosteum
remain to be characterized at the cellular and molecular
levels. Cells may respond differently to systemic growth
factors by expressing various types of receptors or different
levels of these receptors. Indeed, several reports indicate
that cells within periosteum, endosteum, and bone marrow
may not be equally sensitive to mechanical or biological
stimuli.
(35,36)
In addition, cell fate decisions within periosteum and
bone marrow/endosteum are shown here to be regulated
by the tissue environment. The degree of injury may in-
ﬂuence the secretion of various growth factors that are
FIG. 4. Osteoblasts/osteocytes originate from periosteum and en-
dosteum/bone marrow during healing of nonstabilized fractures.
Longitudinal sections through the fracture callus stained with TC
(left) and adjacent sections stained with X-gal (right) 14 days after
bone grafting and nonstable fracture. X-gal–positive osteoblasts
and osteocytes (arrow) are found at the intact periosteal surface (A
and B), at the intact endosteal surface (C and D), within the mar-
row cavity (E and F), and at both the periosteal and endosteal
surfaces in positive controls (G–I), but not in negative controls (J–
L). Osteoclasts exhibit endogenous b-galactosidase activity (K and
L, arrowheads). Asterisk indicates decreased bone bridging in the
anterior part of the callus when the periosteum is removed. Dotted
orange lines delimit the bone graft and black dotted line delimits
the junction between cartilage and bone. b, bone; c, cartilage. Scale
bars: A, C, E, G, and J = 1 mm; B, D, F, H, I, K, and L = 100 mm.
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Fig. 4 is 4/Cdistributed unevenly within the callus and elicit different
cellular responses within periosteum, endosteum, and bone
marrow. For example, prochondrogenic signals may be
increased at the periosteal surface of bone. Moreover,
previous work shows that the program of bone healing is
largely inﬂuenced by the mechanical environment, which
may impact cell differentiation.
(3,4,26,37,38)
Fate of cells in human therapies
A better understanding of the fate of cells within the
fracture callus is necessary to assess the success of future
cell-based therapies. Several methods can be used to en-
hance bone repair in human, such as iliac crest bone grafts,
cortical bone grafts, and periosteal grafts.
(39–44) Whether
MSCs from bone marrow or other sources actually con-
tribute to repair or support healing by providing factors
inducing chondrogenesis or osteogenesis is not known.
(45–
48) MSCs from the bone marrow have been shown to dif-
ferentiate into osteoblasts and chondrocytes in vitro and
are largely used in multiple tissue engineering ap-
proaches.
(49–51) Data show here that cells derived from
bone marrow behave differently when they are recruited
from their original niche because they mainly support os-
teogenesis in vivo. Although MSCs remain the most
promising source of cells for human therapy, the mode of
delivery and the fate of these cells once transplanted in
vivo need to be considered. We previously showed that
bone marrow transplantation was not a successful method
to provide osteoblasts and chondrocytes to the fracture
site.
(4,23) We suspected that donor cells did not populate
the MSC compartment of the host or that the engrafted
MSCs were not recruited during healing. In addition, the
contribution of bone marrow cells recruited from a dis-
tance or circulating stem cells/progenitors is still debat-
able.
(9,52,53) Similarly, the contribution of surrounding soft
tissues to bone healing is unclear.
(54) Further study will be
FIG. 5. Effect of the tissue environment on cell differentiation in the periosteum and endosteum/bone marrow. (A and H) Schematic
representation of Rosa 26 bone grafts (blue) with periosteum (PO, yellow) placed in the environment of endosteum/bone marrow or with
endosteum/bone marrow (EO/BM, red) placed in the environment of the periosteum. Arrows indicates where the fracture is created.
Sections through the bone graft were stained with TC (B, D, I, and K) and SO (F and M) and adjacent sections stained with X-gal (C, E,
G, J, L, and N) at 10 (F, G, M, and N) and 14 (B–E and I–L) days after surgery. During bone graft (B and C) and nonstabilized fracture
healing (D and E), X-gal–positive osteoblasts and osteocytes (arrow) derived from PO are found at the periosteal surface of the graft in
the host bone marrow. (F and G) X-gal–positive chondrocytes (arrow) are detected in the same location. X-gal–positive osteoblasts and
osteocytes (arrow) derived from EO/BM are located at the endosteal surface of the graft facing the host PO during bone graft (I and J)
andnonstabilizedfracturehealing(KandL).(M andN)Onlyfew X-gal–positive chondrocytes (arrow)arefoundin cartilageislandsnear
the endostealsurfaceof graft.Dottedorangelines delimitthe bonegraft and black dottedline delimitsthe junctionbetweencartilageand
bone. b, bone; c, cartilage. Scale bars: B, D, F, I, K, and M = 1 mm; C, E, G, J, L, and N = 100 mm.
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Fig. 5 is 4/Cnecessary to establish the relative contributions of various
sources of stem cells/progenitors compared with the local
periosteum and bone marrow/endosteum.
Conclusion
Results from this study provide direct evidence that the
periosteum, endosteum, and bone marrow are major
sources of skeletal stem cells/progenitors and contribute
differently to osteogenesis and chondrogenesis during
bone repair. The distinct cellular contributions of perios-
teum, endosteum, and bone marrow suggest both intrinsic
differences within the populations of stem cells/progenitors
residing in these tissues and differences in their tissue en-
vironment. Establishing the nature of these differences
and, in particular, identifying the sources of adult skeletal
stem cells/progenitors in vivo, will have profound impli-
cations for the treatment of recalcitrant fractures and bone
diseases.
ACKNOWLEDGMENTS
The author thanks Shirley Lieu for expert technical support
with animal surgery, tissue processing, and analyses; Yan Yiu
Yu for help with bone graft surgery; Chuanyong Lu for help
with endosteal/bone marrow injuries; and Chuanyong Lu and
Ralph Marcucio for comments on the manuscript. This work
was supported by grants from NIH/NIA (R01 AG23218-01 to
Z Werb), NIH/NIDCR (R03 DE16701), Musculoskeletal
Transplant Foundation, and UCSF Research Evaluation and
Allocation Committee (to CC).
REFERENCES
1. Zhang X, Schwarz EM, Young DA, Puzas JE, Rosier RN,
O’Keefe RJ 2002 Cyclooxygenase-2 regulates mesenchymal
cell differentiation into the osteoblast lineage and is critically
involved in bone repair. J Clin Invest 109:1405–1415.
2. Lu C, Miclau T, Hu D, Marcucio RS 2007 Ischemia leads to
delayed union during fracture healing: A mouse model. J
Orthop Res 25:51–61.
3. Colnot C, Thompson Z, Miclau T, Werb Z, Helms JA 2003
Altered fracturerepairin the absenceof MMP9.Development
130:4123–4133.
4. Behonick DJ, Xing Z, Lieu S, Buckley JM, Lotz JC, Marcucio
RS, Werb Z, Miclau T, Colnot C 2007 Role of matrix metal-
loproteinase 13 in both endochondral and intramembranous
ossiﬁcation during skeletal regeneration. PLoS One 2:e1150.
5. Tsuji K, Bandyopadhyay A, Harfe BD, Cox K, Kakar S,
Gerstenfeld L, Einhorn T, Tabin CJ, Rosen V 2006 BMP2
activity, although dispensable for bone formation, is required
for the initiation of fracture healing. Nat Genet 38:1424–1429.
6. Street J, Bao M, deGuzman L, Bunting S, Peale FV Jr, Ferrara
N, Steinmetz H, Hoeffel J, Cleland JL, Daugherty A, van
Bruggen N, Redmond HP, Carano RA, Filvaroff EH 2002
Vascular endothelial growth factor stimulates bone repair by
promoting angiogenesis and bone turnover. Proc Natl Acad
Sci USA 99:9656–9661.
7. Kuznetsov SA, Mankani MH, Gronthos S, Satomura K,
Bianco P, Robey PG 2001 Circulating skeletal stem cells. J
Cell Biol 153:1133–1139.
8. Farrington-Rock C, Crofts NJ, Doherty MJ, Ashton BA, Grif-
ﬁn-Jones C, Canﬁeld AE 2004 Chondrogenic and adipogenic
potentialofmicrovascularpericytes.Circulation110:2226–2232.
9. Otsuru S, Tamai K, Yamazaki T, Yoshikawa H, Kaneda Y
2008 Circulating bone marrow-derived osteoblast progenitor
cells are recruited to the bone-forming site by the CXCR4/
stromal cell-derived factor-1 pathway. Stem Cells 26:223–
234.
10. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R,
Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak
DR 1999 Multilineage potential of adult human mesenchymal
stem cells. Science 284:143–147.
11. Friedenstein AJ, Piatetzky S II, Petrakova KV 1996 Osteo-
genesis in transplants of bone marrow cells. J Embryol Exp
Morphol 16:381–390.
12. Bianco P, Robey PG 2000 Marrow stromal stem cells. J Clin
Invest 105:1663–1668.
13. Spitzer RS, Perka C, Lindenhayn K, Zippel H 2002 Matrix
engineering for osteogenic differentiation of rabbit perios-
teal cells using alpha-tricalcium phosphate particles in a three-
dimensional ﬁbrin culture. J Biomed Mater Res 59:690–696.
14. Gruber R, Mayer C, Bobacz K, Krauth MT, Graninger W,
Luyten FP, Erlacher L 2001 Effects of cartilage-derived
morphogenetic proteins and osteogenic protein-1 on oste-
ochondrogenic differentiation of periosteum-derived cells.
Endocrinology 142:2087–2094.
15. Lee JY, Qu-Petersen Z, Cao BH, Kimura S, Jankowski R,
Cummins J, Usas A, Gates C, Robbins P, Wernig A, Huard J
2000 Clonalisolationof muscle-derived cells capable ofenhancing
muscle regeneration and bone healing. J Cell Biol 150:1085–1099.
16. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ,
Benhaim P, Lorenz HP, Hedrick MH 2001 Multilineage cells
from human adipose tissue: Implications for cell-based thera-
pies. Tissue Eng 7:211–228.
17. BiY,EhirchiouD,KiltsTM,InksonCA,EmbreeMC,Sonoyama
W, Li L, Leet AI, Seo BM, Zhang L, Shi S, Young MF 2007
Identiﬁcation of tendon stem/progenitor cells and the role of
the extracellular matrix in their niche. Nat Med 13:1219–1227.
18. Utvag SE, Grundnes O, Reikeraos O 1996 Effects of perios-
teal stripping on healing of segmental fractures in rats. J Or-
thop Trauma 10:279–284.
19. Ozaki A, Tsunoda M, Kinoshita S, Saura R 2000 Role of
fracture hematoma and periosteum during fracture healing
in rats: Interaction of fracture hematoma and the periosteum
in the initial step of the healing process. J Orthop Sci 5:
64–70.
20. Zhang X, Naik A, Xie C, Reynolds D, Palmer J, Lin A, Awad
H, Guldberg R, Schwarz E, O’Keefe R 2005 Periosteal stem
cells are essential for bone revitalization and repair. J Mus-
culoskelet Neuronal Interact 5:360–362.
21. Devine MJ, Mierisch CM, Jang E, Anderson PC, Balian G
2002 Transplanted bone marrow cells localize to fracture cal-
lus in a mouse model. J Orthop Res 20:1232–1239.
22. ShirleyD, MarshD,JordanG,McQuaidS, Li G2005Systemic
recruitment of osteoblastic cells in fracture healing. J Orthop
Res 23:1013–1021.
23. Colnot C, Huang S, Helms J 2006 Analyzing the cellular
contribution of bone marrow to fracture healing using bone
marrow transplantation in mice. Biochem Biophys Res
Commun 350:557–561.
24. Colnot C, de la Fuente L, Huang S, Hu D, Lu C, St-Jacques B,
Helms JA 2005 Indian hedgehog synchronizes skeletal angi-
ogenesis and perichondrial maturation with cartilage devel-
opment. Development 132:1057–1067.
25. Colnot C, Lu C, Hu D, Helms JA 2004 Distinguishing
the contributions of the perichondrium, cartilage and vas-
cular endothelium to skeletal development. Dev Biol 269:
55–69.
26. Thompson Z, Miclau T, Hu D, Helms JA 2002 A model for
intramembranous ossiﬁcation during fracture healing. J Or-
thop Res 20:1091–1098.
27. Minasi MG, Riminucci M, De Angelis L, Borello U, Berarducci
B, Innocenzi A, Caprioli A, Sirabella D, Baiocchi M, De Maria
R, Boratto R, Jaffredo T, Broccoli V, Bianco P, Cossu G 2002
The meso-angioblast: A multipotent, self-renewing cell that
originates from the dorsal aorta and differentiates into most
mesodermal tissues. Development 129:2773–2783.
CELL FATE DECISIONS DURING SKELETAL REGENERATION 28128. Utvag SE, Grundnes O, Reikeras O 1998 Effects of lesion
between bone, periosteum and muscle on fracture healing in
rats. Acta Orthop Scand 69:177–180.
29. Shimizu T, Sasano Y, Nakajo S, Kagayama M, Shimauchi H
2001 Osteoblastic differentiation of periosteum-derived cells is
promoted by the physical contact with the bone matrix in vivo.
Anat Rec 264:72–81.
30. Landry PS, Marino AA, Sadasivan KK, Albright JA 2000
Effect of soft-tissue trauma on the early periosteal response of
bone to injury. J Trauma 48:479–483.
31. Utvag SE, Grundnes O, Reikeras O 1998 Effects of degrees of
reaming on healing of segmental fractures in rats. J Orthop
Trauma 12:192–199.
32. Bruder SP, Fink DJ, Caplan AI 1994 Mesenchymal stem cells
in bone development, bone repair, and skeletal regeneration
therapy. J Cell Biochem 56:283–294.
33. Bianco P, Robey PG 1999 Diseases of bone and the stromal
cell lineage. J Bone Miner Res 14:336–341.
34. Heissig B, Hattori K, Dias S, Ferris B, Friedrich M, Hackett
NR, Lyden D, Wood J, Crystal RG, Moore MAS, Werb Z,
Raﬁi S 2002 Recruitment of stem and progenitor cells from
the bone marrow niche requires MMP-9-mediated release of
Kit ligand. Cell 109:625–637.
35. Midura RJ, Su X, Morcuende JA, Tammi M, Tammi R 2003
Parathyroid hormone rapidly stimulates hyaluronan synthesis
by periosteal osteoblasts in the tibial diaphysis of the growing
rat. J Biol Chem 278:51462–51468.
36. LaMothe JM, Hamilton NH, Zernicke RF 2005 Strain rate
inﬂuences periosteal adaptation in mature bone. Med Eng
Phys 27:277–284.
37. Miclau T, Lu C, Thompson Z, Choi P, Puttlitz C, Marcucio R,
Helms JA 2007 Effects of delayed stabilization on fracture
healing. J Orthop Res 25:1552–1558.
38. Carter DR, Beaupre ´ GS, Giori NJ, Helms JA 1998 Mecha-
nobiology of skeletal regeneration. Clin Orthop Relat Res
37(Suppl):S41–S55.
39. Einhorn TA 1999 Clinically applied models of bone regener-
ation in tissue engineering research. Clin Orthop Relat Res
38(Suppl):S59–S67.
40. Sen MK, Miclau T 2007 Autologous iliac crest bone graft:
Should it still be the gold standard for treating nonunions?
Injury 38(Suppl 1):S75–S80.
41. Khan SN, Cammisa FP Jr, Sandhu HS, Diwan AD, Girardi
FP, Lane JM 2005 The biology of bone grafting. J Am Acad
Orthop Surg 13:77–86.
42. Jensen L, Back K 1992 Periosteal transplantation in the treatment
of osteochondritis dissecans. Scand J Med Sci Sports 2:32–36.
43. Karaoglu S, Baktir A, Kabak S, Arasi H 2002 Experimental
repair of segmental bone defects in rabbits by demineralized
allograft covered by free autogenous periosteum. Injury 33:
679–683.
44. Perka C, Schultz O, Spitzer RS, Lindenhayn K, Burmester
GR, Sittinger M 2000 Segmental bone repair by tissue-
engineered periosteal cell transplants with bioresorbable
ﬂeece and ﬁbrin scaffolds in rabbits. Biomaterials 21:1145–
1153.
45. Helms JA, Amasha RR, Leucht P 2007 Bone voyage: An ex-
pedition into the molecular and cellular parameters affecting
bone graft fate. Bone 41:479–485.
46. Milbrandt T, Berthoux L, Christenson V, Baumbusch C,
Rekosh D, Balian G, Diduch D 2003 Tracing transduced cells
in osteochondral defects. J Pediatr Orthop 23:430–436.
47. Arinzeh TL, Peter SJ, Archambault MP, van den Bos C,
Gordon S, Kraus K, Smith A, Kadiyala S 2003 Allogeneic
mesenchymal stem cells regenerate bone in a critical-sized
canine segmental defect. J Bone Joint Surg Am 85:1927–
1935.
48. Gamradt SC, Lieberman JR 2003 Bone graft for revision hip
arthroplasty: Biology and future applications. Clin Orthop
Relat Res 417:183–194.
49. Lieberman JR, Daluiski A, Stevenson S, Wu L, McAllister P,
Lee YP, Kabo JM, Finerman GA, Berk AJ, Witte ON 1999
The effect of regional gene therapy with bone morphogenetic
protein-2-producing bone-marrow cells on the repair ofsegmental
femoral defects in rats. J Bone Joint Surg Am 81:905–917.
50. Geesink RG, Hoefnagels NH, Bulstra SK 1999 Osteogenic
activity of OP-1 bone morphogenetic protein (BMP-7) in a
human ﬁbular defect. J Bone Joint Surg Br 81:710–718.
51. Togel F, Westenfelder C 2007 Adult bone marrow-derived
stem cells for organ regeneration and repair. Dev Dyn 236:
3321–3331.
52. Taguchi K, Ogawa R, Migita M, Hanawa H, Ito H, Orimo H
2005 The role of bone marrow-derived cells in bone fracture
repair in a green ﬂuorescent protein chimeric mouse model.
Biochem Biophys Res Commun 331:31–36.
53. Otsuru S, Tamai K, Yamazaki T, Yoshikawa H, Kaneda Y
2007 Bone marrow-derived osteoblast progenitor cells in cir-
culating blood contribute to ectopic bone formation in mice.
Biochem Biophys Res Commun 354:453–458.
54. Wright V, Peng H, Usas A, Young B, Gearhart B, Cummins J,
Huard J 2002 BMP4-expressing muscle-derived stem cells
differentiate into osteogenic lineage and improve bone healing
in immunocompetent mice. Mol Ther 6:169–178.
Address reprint requests to:
Ce ´line Colnot, PhD
Department of Orthopaedic Surgery
University of California at San Francisco
San Francisco General Hospital
1001 Potrero Avenue, Box 1342
San Francisco, CA 94110, USA
E-mail: colnotc@orthosurg.ucsf.edu
Received in original form April 23, 2008; revised form August 1,
2008; accepted October 7, 2008.
282 COLNOT